ArticleJournal of surgical case reports2026
Thymic hyperplasia after chemotherapy for ovarian malignancy: two cases complicated by hyperthyroidism.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thymic hyperplasia is a benign condition in which the thymus enlarges in response to various stimuli. It occasionally occurs after chemotherapy for hematologic malignancies or in association with hyperthyroidism, but no previous reports describe cases in which multiple causes coexist. We present two cases of thymic hyperplasia occurring after chemotherapy for ovarian malignancy, both accompanied by concurrent hyperthyroidism. Case 1 was a 29-year-old woman with ovarian dysgerminoma, Stage IC1, and Case 2 was a 46-year-old woman with ovarian high-grade serous carcinoma, Stage IIIB; both patients received surgery and chemotherapy. Twelve and twenty-four months after completion of chemotherapy, computed tomography revealed an anterior mediastinal mass. Additional imaging showed no malignant features. They were diagnosed with thymic hyperplasia. Screening tests later identified hyperthyroidism in both women, and medical therapy was initiated. These cases highlight that thyroid function testing should be considered when thymic hyperplasia is detected in young female patients with malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.